A New Generation of Drugs Could Lower Heart Attack Risk for Millions

新一代药物有望降低数百万人患心脏病的风险

WSJ What’s News

2026-05-28

13 分钟
PDF

单集简介 ...

P.M. Edition for May 27. Pharmaceutical companies have been testing a new type of drug to lower levels of lipoprotein(a); high levels have been linked to heart disease and can’t be lowered with diet and exercise. WSJ reporter Xavier Martinez walks us through how the new drugs work and what is still needed before they can make their way to patients. Plus, Ford’s stock has been surging for the past two weeks, but the reason doesn’t have much to do with cars. Journal autos reporter Ryan Felton discusses. And President Trump says he doesn’t fear political fallout from the Iran war, while the U.S. blockade throttles the Iranian economy. We hear from WSJ Middle East correspondent Benoit Faucon about what that economic pressure means for both sides as they seek a deal for long-term peace. Alex Ossola hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
更多

单集文稿 ...

  • This is a new era of American innovation.

  • Google is offering free AI training to U.S. small businesses with the Google

  • AI Professional Certificate so they can start using AI to get more done.

  • Find out more at grow.google.com.

  • A new class of drugs could help millions of people

  • lower their risk of heart attacks if the companies can show the medicine actually works.

  • Let's say that the drugs actually do help translate to better cardiovascular outcomes.

  • They also have to show that they have a meaningful benefit.

  • Plus, Ford's stock is popping for a reason that has nothing to do with cars.

  • And Iran's battered economy is proving a key factor in peace negotiations with the U.S.

  • The Navy is good.

  • The Air Force is good.

  • Everything's gone and they're negotiating on fumes.

  • It's Wednesday, May 27th.

  • I'm Alex Ossola for The Wall Street Journal.

  • This is the P.M.

  • edition of What's News, the top headlines and business stories that move the world today.

  • Tens of millions of Americans have elevated levels of lipoprotein A, a fatty particle in the blood.

  • It's a variant of LDL, the bad cholesterol, and a driver of heart disease.

  • Scientists have been chasing treatments for decades with little to show for it.